27.66新台幣0.04(0.14%)
2024/07/23更新
績效 / 1月4.77%
3月10.77%
1年19.48%
晨星評等 - 1.現金9.17%
- 2.股票22.65%
- 3.債券0.00%
- 4.其他68.18%
- 1.美國68.88%
- 2.歐洲不包含歐元區13.95%
- 3.英國7.37%
- 4.日本1.32%
- 1.Eli Lilly and Co9.43%
- 2.Regeneron Pharmaceuticals Inc9.27%
- 3.Vertex Pharmaceuticals Inc9.18%
- 4.Novo Nordisk A/S Class B9.00%
- 5.AstraZeneca PLC7.37%
- 6.Amgen Inc6.78%
- 7.Gilead Sciences Inc4.86%
- 8.Neurocrine Biosciences Inc4.20%
- 9.AbbVie Inc3.45%
- 10.Boston Scientific Corp3.43%
- 1.現金9.17%
- 2.股票22.65%
- 3.債券0.00%
- 4.其他68.18%
- 1.美國68.88%
- 2.歐洲不包含歐元區13.95%
- 3.英國7.37%
- 4.日本1.32%
- 1.Eli Lilly and Co9.43%
- 2.Regeneron Pharmaceuticals Inc9.27%
- 3.Vertex Pharmaceuticals Inc9.18%
- 4.Novo Nordisk A/S Class B9.00%
- 5.AstraZeneca PLC7.37%
- 6.Amgen Inc6.78%
- 7.Gilead Sciences Inc4.86%
- 8.Neurocrine Biosciences Inc4.20%
- 9.AbbVie Inc3.45%
- 10.Boston Scientific Corp3.43%